I was watching 9 news last night and noted the report about Roche's Atezolizumab (Tencentriq) being listed on the PBS, and what this means in terms of accessability of teatment for those suffering from Non-Small Cell Lung Cancer. I hope this enables a further escalation and expansion of IMU's PD1-Vaxx combination study with Atezolizumab. Any views out there? Is there a possibility Roche could become our permanent dance partner? I vaguely remember IMU ending one of is combination study partnerships, but I just can't recall which one. Anyway here's a link to the report for those interested.
https://www.9news.com.au/health/tecentriq-injection-lifesaving-lung-and-liver-cancer-jab-added-to-pbs/785aa82e-d9f7-4bbb-b043-d8ad22b85df5
Media Thread, page-14999
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $389.5M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.5¢ | 5.3¢ | $172.3K | 3.206M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 570320 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 442049 | 19 |
View Market Depth
| Last trade - 15.58pm 01/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |